AstraZeneca

Contact
astrazeneca.at
+43171131-0

AstraZeneca Österreich GmbH

Schwarzenbergplatz 7
1037 Wien
Austria
+43171131-0
astrazeneca.at
Contact
Profile News
Contact

About AstraZeneca

As the Austrian subsidiary of the British-Swedish group, AstraZeneca Österreich GmbH is one of the leading pharmaceutical companies in Austria. The product portfolio comprises 7 therapeutic areas with leading, innovative drugs.

Note: This article has been translated using a computer system without human intervention. LUMITOS offers these automatic translations to present a wider range of company presentation. Since this article has been translated with automatic translation, it is possible that it contains errors in vocabulary, syntax or grammar. The original article in German can be found here.

Read more about AstraZeneca
Facts about AstraZeneca
  • Industry : Pharma

News about AstraZeneca

AstraZeneca

18-Jul-2024 | business & finance

Amolyt Pharma completes acquisition by AstraZeneca

AstraZeneca has acquired all of Amolyt Pharma’s outstanding shares for up to $1.05 billion

Read news
AstraZeneca

03-Nov-2023 | business & finance

Cellectis enters into strategic collaboration and investment agreement with AstraZeneca

Cellectis to receive up to $245M in cash, with potential for additional milestones, plus tiered royalties

Read news
AstraZeneca

12-Oct-2023 | research and development

SAS accelerates delivery of novel medicines using AI and analytics

Cooperation with AstraZeneca for more innovation in clinical research

Read news
AstraZeneca

05-Oct-2021 | business & finance

VaxEquity Announces Strategic Collaboration with AstraZeneca to Commercialise Self-Amplifying RNA Platform

VaxEquity receives upfront equity investment and up to $195 million and royalties in the mid-single digits per programme

Read news
AstraZeneca

29-Jul-2021 | business & finance

AstraZeneca and Regeneron to research, develop and commercialise new small molecule medicines for obesity

Novel small molecule drug candidates will target GPR75 to potentially address obesity and related co-morbidities

Read news
AstraZeneca

28-Jul-2020 | business & finance

AstraZeneca and Daiichi Sankyo enter collaboration to develop and commercialise new antibody drug conjugate

Potential new medicine could redefine treatment standards in lung, breast and multiple other cancers

Read news
AstraZeneca

02-May-2019 | business & finance

AstraZeneca starts collaboration with start-up BenevolentAI

Collaboration will use artificial intelligence to discover potential new drugs

Read news
AstraZeneca

07-Feb-2017 | business & finance

Bachem renews supply contract with AstraZeneca

The Bachem Group announced the renewal of its supply agreement with AstraZeneca for the peptide active substance Goserelin. The extended partnership ...

Read news
Show more news about AstraZeneca

Here you will find AstraZeneca Österreich GmbH